One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a compounded, off-brand version of its blockbuster weight-loss medications.

Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price tags of over $1,000 a month.

Injectable prescription drugs that reduce appetite — like Ozempic, Saxenda and Mounjaro — have skyrocketed in popularity in recent years.

Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to set them up with Wegovy, Zepbound and other weight-loss drugs.

Four key factors can greatly impact how much weight people lose while taking GLP-1 drugs like Ozempic, Wegovy, Victoza, and Saxenda. Here's what to know.

In a society that has so many people who are overweight, it is understandable there’s such a craze for new drugs that are helping people to lose weight. Drugs like Ozempic and Wegovy were developed for people with diabetes but have proven to be great resources for losing weight.

People taking the experimental drug amycretin were found to lose almost twice as much weight over a 12-week period as the average weight loss seen with semaglutide.

Daily” pill is the latest product to capitalize on the weight loss drug craze. By Dani Blum There’s a long list of products that companies and influencers claim can deliver quick and dramatic weight loss,

In July, the U.S. Food and Drug Administration warned that people are overdosing on compounded semaglutide injectable products.